Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Association Between 9p21 Genomic Markers and Heart Disease

Association Between 9p21 Genomic Markers and Heart Disease CLINICAL REVIEW CLINICIAN’S CORNER Association Between 9p21 Genomic Markers and Heart Disease A Meta-analysis Glenn E. Palomaki, BS Context Associations between chromosome 9p21 single-nucleotide polymorphisms Stephanie Melillo, MPH (SNPs) and heart disease have been reported and replicated. If testing improves risk as- sessments using traditional factors, it may provide opportunities to improve public health. Linda A. Bradley, PhD Objectives To perform a targeted systematic review of published literature for effect REVENTING AND MANAGING CAR- size, heterogeneity, publication bias, and strength of evidence and to consider whether diovascular disease (CVD) pre- testing might provide clinical utility. sents a challenge for health care Data Sources Electronic search via HuGE Navigator through January 2009 and re- 1,2 Pand public health. Nonmodi- view of reference lists from included articles. fiable risk factors include increasing age, Study Selection English-language articles that tested for 9p21 SNPs with coronary male sex, and heredity. Modifiable risk heart/artery disease or myocardial infarction as primary outcomes. Included articles factors include smoking, hypertension, also provided race, numbers of participants, and data to compute an odds ratio (OR). dyslipidemia, obesity, physical inactiv- Articles were excluded if reporting only intermediate outcomes (eg, atherosclerosis) 3-5 ity, and diabetes. Among men, the an- or http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Association Between 9p21 Genomic Markers and Heart Disease

JAMA , Volume 303 (7) – Feb 17, 2010

Loading next page...
 
/lp/american-medical-association/association-between-9p21-genomic-markers-and-heart-disease-13n7M5aKdL
Publisher
American Medical Association
Copyright
Copyright 2010 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.2010.118
pmid
20159873
Publisher site
See Article on Publisher Site

Abstract

CLINICAL REVIEW CLINICIAN’S CORNER Association Between 9p21 Genomic Markers and Heart Disease A Meta-analysis Glenn E. Palomaki, BS Context Associations between chromosome 9p21 single-nucleotide polymorphisms Stephanie Melillo, MPH (SNPs) and heart disease have been reported and replicated. If testing improves risk as- sessments using traditional factors, it may provide opportunities to improve public health. Linda A. Bradley, PhD Objectives To perform a targeted systematic review of published literature for effect REVENTING AND MANAGING CAR- size, heterogeneity, publication bias, and strength of evidence and to consider whether diovascular disease (CVD) pre- testing might provide clinical utility. sents a challenge for health care Data Sources Electronic search via HuGE Navigator through January 2009 and re- 1,2 Pand public health. Nonmodi- view of reference lists from included articles. fiable risk factors include increasing age, Study Selection English-language articles that tested for 9p21 SNPs with coronary male sex, and heredity. Modifiable risk heart/artery disease or myocardial infarction as primary outcomes. Included articles factors include smoking, hypertension, also provided race, numbers of participants, and data to compute an odds ratio (OR). dyslipidemia, obesity, physical inactiv- Articles were excluded if reporting only intermediate outcomes (eg, atherosclerosis) 3-5 ity, and diabetes. Among men, the an- or

Journal

JAMAAmerican Medical Association

Published: Feb 17, 2010

References